Allogene Therapeutics, Inc.
ALLO
DELAYED 1 MONTH

1 insider filing · Latest: Mar 2, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Mar 2, 2026Mar 4 10:42 PMBenjamin Machinas BeneskiSVP, Chief Technical Officer
Sale
7,132$2.60$18.5K203,040(D)

View →

Stock Options & Derivatives

No transactions found.